Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity-Reference-Cited by-同舟云学术

Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity

Published:2022-01-05 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wang Hanfeng¹,Fan Yang¹,Chen Weihao¹²,Lv Zheng³,Wu Shengpan¹,Xuan Yundong¹²,Wang Chenfeng¹²,Lu Yongliang¹²,Guo Tao²⁴,Shen Donglai¹,Zhang Fan¹,Huang Qingbo¹,Gao Yu¹,Li Hongzhao¹,Ma Xin¹,Wang Baojun¹,Huang Yan¹,Zhang Xu¹

Affiliation:

1. Senior Department of Urology, The Third Medical Center of PLA General Hospital, Beijing, China

2. Medical School of Chinese PLA, Beijing, China

3. School of Medicine, Nankai University, Tianjin, China

4. Senior Department of Paediatrics, The Seventh Medical Center of PLA General Hospital, Beijing, China

Funder

National Natural Science Foundation of China

Fostering Fund of Chinese PLA General Hospital for National Distinguished Young Scholar Science Fund

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.2011673

Reference57 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

3. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

4. Treatment of renal cell carcinoma: Current status and future directions

5. Medical treatment of renal cancer: new horizons

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms and correlation of CMTM6 and PD-L1 inhibitors in colorectal cancer treatment;Asian Journal of Surgery;2024-09

2. NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma;The Journal of Pathology;2024-08-02

3. Epigenetic regulations of cellular senescence in osteoporosis;Ageing Research Reviews;2024-08

4. CMTM6 promotes hepatocellular carcinoma progression through stabilizing β-catenin;Cancer Letters;2024-02

5. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors;PeerJ;2024-01-10